04 November 2013

ERBA Diagnostics Opens New Subsidiary in Mexico

Miami Lakes, Fla. – 04 November 2013 - ERBA Diagnostics Inc. announced the opening of its wholly-owned subsidiary, ERBA Diagnostics Mexico S.A., located in Mexico City. This new subsidiary is ERBA Diagnostics’ fifth wholly-owned subsidiary.

ERBA Mexico is in the process of employing a team of sales specialists and customer support engineers, which is expected to increase sales through improved customer support and brand image. ERBA Mexico is being equipped with a sales and service training center in an effort to provide better support to ERBA Diagnostics’ distributors and customers in over 20 counties of Latin America, with an aggregate population of over 600 million.

The IVD market in Mexico is estimated by market researchers to be approximately $ 400 million, with 70% of such market being composed of Immunochemistry (32 %), Hematology / Coagulation (14%) and Chemistry / Urine analysis (25%). The Mexican market for diagnostics is expected by market researchers to continue to grow at the rate of approximately 15% per year.

ERBA Diagnostics, Inc., headquartered in Miami Lakes, Florida, is a fully integrated in vitro diagnostics company that develops, manufactures and distributes in the United States and internationally, proprietary diagnostic reagents, test kits and instrumentation, primarily for autoimmune and infectious diseases.

Source: ERBA Diagnostics